Bank of America
CANF

Bank of America’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

Bank of America’s Portfolio CANF Stock Details CANF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Hold
0
– -$6 – 8331
2025
Q2 		– Hold
0
– – – 8314
2022
Q2 		– Sell
-2
Closed – – 8035
2022
Q1 		$0 Hold
2
– – ﹤0.01% 8283
2021
Q4 		$1K Buy
+2
New +$551 ﹤0.01% 8038
2019
Q3 		– Hold
0
– – – 7263
2019
Q2 		– Hold
0
– – – 7190

Other funds holding CANF

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
BWL
Bogart Wealth LLC Mclean, Virginia $2.92B AUM 23.85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America's CANF Position: Q3 2025 in Review

Bank of America held its Can-Fite BioPharma American Depositary Shares (CANF) position steady in Q3 2025 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #8331.

Bank of America first reported a position in CANF in Q4 2021 and has held it in 2 quarters since. The position peaked at $1K in Q4 2021. 15 funds tracked by Wall St. Rank hold CANF as of Q3 2025.

  • Bank of America held 0 shares of Can-Fite BioPharma American Depositary Shares worth $0 as of Q3 2025.
  • Bank of America left its Can-Fite BioPharma American Depositary Shares share count unchanged in Q3 2025.
  • Can-Fite BioPharma American Depositary Shares made up ﹤0.01% of Bank of America's portfolio in Q3 2025, its #8331 holding.
  • Bank of America first reported a position in Can-Fite BioPharma American Depositary Shares in Q4 2021 and has held it in 2 quarters since.
  • Bank of America's Can-Fite BioPharma American Depositary Shares position peaked at $1K in Q4 2021.
  • 15 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q3 2025.

Based on Bank of America's 13F filing for Q3 2025, filed 14 Nov 2025.